ADC lsotype Control Human IgG1 (MMAF)

製品番号/仕様
価格
Availability
数量
DNP-C904P1-100ug
$195.00
In Stock - Delivery in 1-2 business days
DNP-C904P1-1mg (500ug X 2)
$790.00
DNP-C904P1
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Source

ADC lsotype Control Human IgG1 (MMAF) is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to human IgG1 constant domains.

Antibody Type

Recombinant Monoclonal

Clone

AM1

Isotype

Human IgG1, Kappa

Host Species

Mouse

DAR

4

Purification

Protein A purified.

Aggregation

Less than 10%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

バックグランド

MMAF (Monomethyl auristatin F) is an auristatin-derived microtubule inhibitor. With a mechanism of action similar to MMAE, it inhibits tumor cell proliferation by interfering with microtubule dynamics, yet exhibits superior water solubility and plasma stability with lower off-target toxicity. As a cytotoxic payload for ADCs, it is suitable for developing anti-tumor ADCs for MMAE-resistant cases or those requiring reduced systemic toxicity.

ACRO Scientific Leadership Award

Supporting the scientists driving cell & gene therapy forward

Apply Now